Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. Mai 2026 08:00 ET | Quelle: Silexion Therapeutics Corp

Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center

Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with global leading manufacturing partner Catalent at its...
08. Mai 2026 04:03 ET | Quelle: Research and Markets

Spatial Genomics and Transcriptomics Research Report 2026 - Global Market Analysis, Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031

Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Spatial Genomics and Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ...
07. Mai 2026 10:04 ET | Quelle: Research and Markets

Post-Marketing Pharmacovigilance and Medical Information Market Analysis Report 2026: $11.89 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Post-Marketing Pharmacovigilance and Medical Information Market Report 2026" has been added to ResearchAndMarkets.com's offering. The...
30. April 2026 12:06 ET | Quelle: Research and Markets

Biopharmaceutical CMO and CRO Research Report 2026: $48.79 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CMO and CRO Market Report 2026" has been added to ResearchAndMarkets.com's offering. The biopharmaceutical Contract...
30. April 2026 11:57 ET | Quelle: Research and Markets

Topical Drugs Contract Development and Manufacturing Organization (CDMO) Market Research Report 2026: $121 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts 2020-2035

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Topical Drugs Contract Development and Manufacturing Organization (CDMO) Market Report 2026" has been added to ResearchAndMarkets.com's offering. ...
30. April 2026 09:03 ET | Quelle: Sonablate

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Brad Saar joins Sonablate board to support growth of non-invasive prostate cancer treatment to signal next phase of expansion for HIFU-based prostate care.
29. April 2026 11:36 ET | Quelle: Research and Markets

AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, Chemaxon - Global Forecast to 2030 and 2035

Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "AI in Predictive Toxicology Market Report 2026" has been added to ResearchAndMarkets.com's offering. The artificial intelligence (AI) in...
29. April 2026 07:00 ET | Quelle: Denovo Biopharma

Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)

Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)
28. April 2026 09:29 ET | Quelle: Research and Markets

Biosimulation Market Report 2025 with Analyst Insights - Advancements in Precision Oncology and Integration with Digital Twins - Global Forecast to 2030

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Biosimulation Market (2025 Edition)" report has been added to ResearchAndMarkets.com's offering. The growth of this Market is expected to be...
28. April 2026 08:45 ET | Quelle: Silexion Therapeutics Corp

Silexion Therapeutics Announces Successful Submission of Phase 2/3 Clinical Trial Application to Germany’s BfArM for SIL204 in KRAS-Driven Locally Advanced Pancreatic Cancer

Grand Cayman, Cayman Islands, April 28, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA...

Nächste Seite